Cited by 1,975Alzheimer's disease research and treatmentsNeuropeptides and Animal PhysiologyNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index, and 2 are not checked yet.

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Yankner, Bruce A., Duffy, Lawrence K., Kirschner, Daniel A.·1990·Science

DOI 10.1126/science.2218531

Open this paper in CoChat — free account

Abstract

The amyloid β protein is deposited in the brains of patients with Alzheimer's disease but its pathogenic role is unknown. In culture, the amyloid β protein was neurotrophic to undifferentiated hippocampal neurons at low concentrations and neurotoxic to mature neurons at higher concentrations. In differentiated neurons, amyloid β protein caused dendritic and axonal retraction followed by neuronal death. A portion of the amyloid β protein (amino acids 25 to 35) mediated both the trophic and toxic effects and was homologous to the tachykinin neuropeptide family. The effects of the amyloid β protein were mimicked by tachykinin antagonists and completely reversed by specific tachykinin agonists. Thus, the amyloid β protein could function as a neurotrophic factor for differentiating neurons, but at high concentrations in mature neurons, as in Alzheimer's disease, could cause neuronal degeneration.

Integrity signals

Registry

Crossref · 10.1126/science.2218531

Cites

29 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
The establishment of polarity by hippocampal neurons in culture.
Dotti, C., Sullivan, C., & Banker, G. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-04-01454.1988 · Cited by 1,862
Glutamate neurotoxicity in cortical cell culture
Choi, D. W., Maulucci-Gedde, M., & Kriegstein, A. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00357.1987 · Cited by 1,506
Rat hippocampal neurons in dispersed cell culture.
Banker, G. A., & Cowan, W. M. (1977) · Brain Research · doi:10.1016/0006-8993(77)90594-7 · Cited by 1,110
Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.
Masters, C. L., Multhaup, G., Simms, G., Pottgiesser, J., Martins, R. N., & Beyreuther, K. T. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04000.x · Cited by 1,048
Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease
Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907
Self-citation
Outgrowth-regulating actions of glutamate in isolated hippocampal pyramidal neurons
Mattson, M. P., Dou, P., & Kater, S. B. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-06-02087.1988 · Cited by 557
Tachykinins
Maggio, J. E. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.000305 · Cited by 550

Show all 31 references

Research works printed but not linked: 2

Dayhoff, M. O., Atlas of Protein Sequence and Structure 5 3: 345 (1978).
GLENNER, G, BRANBURY REPORT 15: 137 (1983).

Sorted by citations

Items 201–300 of 1,008

Does Donepezil Treatment Slow the Progression of Hippocampal Atrophy in Patients With Alzheimer’s Disease?
Hashimoto, M., Kazui, H., Matsumoto, K., Nakano, Y., Yasuda, M., & Mori, E. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.676 · Cited by 241
An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease
Pappolla, M. A., Chyan, Y., Pöeggeler, B., Frangione, B., Wilson, G. L., Ghiso, J. A., & Reiter, R. J. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050018 · Cited by 241
Phosphorylated Map Kinase (ERK1, ERK2) Expression is Associated with Early Tau Deposition in Neurones and Glial Cells, but not with Increased Nuclear DNA Vulnerability and Cell Death, in Alzheimer Disease, Pick's Disease, Progressive Supranuclear Palsy and Corticobasal Degeneration
Ferrer, I., Blanco, R., Carmona, M., Ribera, R., Goutan, E., Puig, B., Rey, M. J., Cardozo, A., Viñals, F., & Ribalta, T. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00387.x · Cited by 239
Protective effects of idebenone and α‐tocopherol on β‐amyloid‐(1–42)‐induced learning and memory deficits in rats: implication of oxidative stress in β‐amyloid‐induced neurotoxicity in vivo
Yamada, K., Tanaka, T., Han, D., Senzaki, K., Kameyama, T., & Nabeshima, T. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00408.x · Cited by 238
Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F·DP, in B-amyloid-induced Neuronal Death
Giovanni, A., Wirtz-Brugger, F., Keramaris, E., Slack, R. S., & Park, D. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19011 · Cited by 238
Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer’s disease
Urbanc, B., Cruz, L., Le, R., Sanders, J., Ashe, K. H., Duff, K., Stanley, H. E., Irizarry, M. C., & Hyman, B. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222433299 · Cited by 237
Controlling Amyloid β-Peptide Fibril Formation with Protease-stable Ligands
Tjernberg, L. O., Lilliehöök, C., Callaway, D. J. E., Näslund, J., Hahne, S., Thyberg, J., Terenius, L. Y., & Nordstedt, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12601 · Cited by 233
Estradiol protects against β-amyloid (25–35)-induced toxicity in SK-N-SH human neuroblastoma cells
Green, P. S., Gridley, K. E., & Simpkins, J. W. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13148-7 · Cited by 231
Protective effect of the energy precursor creatine against toxicity of glutamate and β-amyloid in rat hippocampal neurons
Brewer, G. J., & Wallimann, T. W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741968.x · Cited by 230
Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease
Yankner, B. A., & Lu, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800018200 · Cited by 229
Self-citation
Mechanisms of Neuroprotection by a Novel Rescue Factor Humanin from Swedish Mutant Amyloid Precursor Protein
Hashimoto, Y., Ito, Y., Niikura, T., Shao, Z., Hata, M., Oyama, F., & Nishimoto, I. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4765 · Cited by 229
Generation of Aggregated β-Amyloid in the Rat Hippocampus Impairs Synaptic Transmission and Plasticity and Causes Memory Deficits
Stéphan, A., Laroche, S., & Davis, S. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05703.2001 · Cited by 228
Molecular mechanism of neurodegeneration induced by Alzheimer’s β-amyloid protein: channel formation and disruption of calcium homeostasis
Kawahara, M., & Kuroda, Y. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00370-1 · Cited by 227
Reactive oxygen species and Alzheimer's disease
Multhaup, G., Ruppert, T., Schlicksupp, A., Hesse, L., Beher, D., Masters, C. L., & Beyreuther, K. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00062-2 · Cited by 228
Fresh and globular amyloid β protein (1–42) induces rapid cellular degeneration: evidence for AβP channel‐mediated cellular toxicity
Bhatia, R., Lin, H., & Lal, R. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1233 · Cited by 226
Amyloid β peptide induces necrosis rather than apoptosis
Behl, C., Davis, J. B., Klier, F. G., & Schubert, D. (1994) · Brain Research · doi:10.1016/0006-8993(94)91659-4 · Cited by 224
In vivo neurotoxicity of beta-amyloid [β(1–40)] and the β(25–35) fragment
Kowall, N. W., McKee, A. C., Yankner, B. A., & Beal, M. F. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90053-z · Cited by 223
Self-citation
Glial activation in Alzheimer's disease: the role of AÎ² and its associated proteins
Meda, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00307-4 · Cited by 222
Detailed Characterization of Neuroprotection by a Rescue Factor Humanin against Various Alzheimer's Disease-Relevant Insults
Hashimoto, Y., Niikura, T., Ito, Y., Sudo, H., Hata, M., Arakawa, E., Abe, Y., Kita, Y. A., & Nishimoto, I. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09235.2001 · Cited by 222
Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons
Kawahara, M., Arispe, N. J., Kuroda, Y., & Rojas, E. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78048-2 · Cited by 222
Regulation of Amyloid Precursor Protein Cleavage
Mills, J., & Reiner, P. B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720443.x · Cited by 222
Amyloid Precursor Protein (APP) and ΒZA4 Amyloid in the Etiology of Alzheimer's Disease: Precursor‐Product Relationships in the Derangement of Neuronal Function
Beyreuther, K., & Masters, C. L. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00667.x · Cited by 221
The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease
Fang, M., Wang, J., Zhang, X., Geng, Y., Hu, Z., Rudd, J. A., Ling, S., Chen, W., & Han, S. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.11.032 · Cited by 221
Nitric oxide and nitroxidative stress in Alzheimer's disease
Malinski, T. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11208 · Cited by 220
Current drug targets for Alzheimer's disease treatment
Lahiri, D. K., Farlow, M. R., Greig, N. H., & Sambamurti, K. (2002) · Drug Development Research · doi:10.1002/ddr.10081 · Cited by 220
Glucocorticoids Enhance Oxidative Stress-Induced Cell Death in Hippocampal Neurons in Vitro
Behl, C., Lezoualc’h, F., Trapp, T., Widmann, M., Skutella, T., & Holsboer, F. (1997) · Endocrinology · doi:10.1210/endo.138.1.4835 · Cited by 220
Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease
Cataldo, A. M., Hamilton, D. J., & Nixon, R. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)91858-9 · Cited by 185
The Alzheimer's Disease Amyloid Precursor Protein Modulates Copper-Induced Toxicity and Oxidative Stress in Primary Neuronal Cultures
White, A. R., Multhaup, G., Maher, F., Bellingham, S. A., Camakaris, J., Zheng, H., Bush, A. I., Beyreuther, K., Masters, C. L., & Cappai, R. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09170.1999 · Cited by 220
Trophic effect of β-amyloid precursor protein on cerebral cortical neurons in culture
Araki, W., Kitaguchi, N., Tokushima, Y., Ishii, K., Aratake, H., Shimohama, S., Nakamura, S., & Kimura, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81412-3 · Cited by 218
Metal Chelation as a Potential Therapy for Alzheimer's Disease
Cuajungco, M. P., Faget, K. Y., Huang, X., Tanzi, R. E., & Bush, A. I. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06938.x · Cited by 220
Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease.
Podlisny, M. B., Tolan, D. R., & Selkoe, D. J. (1991) · PubMed Central · Cited by 217
beta-Amyloid toxicity in organotypic hippocampal cultures: Protection by EUK-8, a synthetic catalytic free radical scavenger
Bruce, A. J., Malfroy, B., & Baudry, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2312 · Cited by 216
A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Aβ25–35
Alkam, T., Nitta, A., Mizoguchi, H., Itoh, A., & Nabeshima, T. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.03.001 · Cited by 216
Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer’s disease
Baker‐Nigh, A., Vahedi, S., Davis, E., Weıntraub, S., Bigio, E. H., Klein, W. L., & Geula, C. (2015) · Brain · doi:10.1093/brain/awv024 · Cited by 211
Brain Imaging of Nicotinic Receptors in Alzheimer's Disease
Wu, J., Ishikawa, M., Zhang, J., & Hashimoto, K. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/548913 · Cited by 211
Methodological variables in the assessment of beta amyloid neurotoxicity
Busciglio, J. A., Lorenzo, A., & Yankner, B. A. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90065-6 · Cited by 211
Self-citation
Rapid Communication: Ca2+ Channel Blockers Attenuate β‐Amyloid Peptide Toxicity to Cortical Neurons in Culture
Weiss, J. H., Pike, C. J., & Cotman, C. W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010372.x · Cited by 211
Tachykinin Receptors: A Radioligand Binding Perspective
Mussap, C., GERAGHTY, D. P., & Burcher, E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03484.x · Cited by 210
Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons.
Kelly, J. F., Furukawa, K., Barger, S. W., Rengen, M., Mark, R. J., Blanc, E. M., Roth, G. S., & Mattson, M. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6753 · Cited by 210
Molecular biology and genetics of Alzheimer's disease
George‐Hyslop, P. S., & Petit-Paitel, A. (2005) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2004.10.013 · Cited by 208
β-Amyloid Fragment 25–35 Causes Mitochondrial Dysfunction in Primary Cortical Neurons
Casley, C. S., Land, J. M., Sharpe, M. A., Clark, J. B., Duchen, M. R., & Canevari, L. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0516 · Cited by 207
Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm
Lal, R., Lin, H., & Quist, A. P. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.04.021 · Cited by 207
β-Amyloid and the Pathogenesis of Alzheimer's Disease
Flier, J. S., Underhill, L. H., Yankner, B. A., & Mesulam, M. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112263252605 · Cited by 208
Self-citation
E2F1 Mediates Death of B-amyloid-treated Cortical Neurons in a Manner Independent of p53 and Dependent on Bax and Caspase 3
Giovanni, A., Keramaris, E., Morris, E. J., Hou, S., O'Hare, M., Dyson, N. J., Robertson, G. S., Slack, R. S., & Park, D. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.11553 · Cited by 206
Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures
Bo, R. D., Angeretti, N., Lucca, E., Simoni, M. G. D., & Forloni, G. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11384-9 · Cited by 206
Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases
Brkic, M., Balusu, S., Libert, C., & Vandenbroucke, R. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/620581 · Cited by 205
Neutral endopeptidase can hydrolyze β-amyloid(1–40) but shows no effect on β-amyloid precursor protein metabolism
Howell, S. W., Nalbantoglu, J. N., & Crine, P. (1995) · Peptides · doi:10.1016/0196-9781(95)00021-b · Cited by 205
Alzheimer Disease
Smith, M. A. (1998) · International review of neurobiology · doi:10.1016/s0074-7742(08)60607-8 · Cited by 206
Alzheimer’s Disease, Oligomers, and Inflammation
Forloni, G., & Balducci, C. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170819 · Cited by 205
Human cathepsin S: chromosomal localization, gene structure, and tissue distribution
Shi, G., Webb, A. C., Foster, K. E., Knoll, J. H. M., Lemere, C. A., Munger, J. S., & Chapman, H. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78156-3 · Cited by 203
NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation.
Yoshimoto, M., Iwai, A., Kang, D. E., Otero, D. A., Xia, Y., & Saitoh, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9141 · Cited by 203
Structure and functions of the human amyloid precursor protein: The whole is more than the sum of its parts
Gralle, M., & Ferreira, S. T. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.02.001 · Cited by 202
Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease
Parri, H. R., Hernandez, C. M., & Dineley, K. T. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.039 · Cited by 187
Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation
Goodman, Y., Steiner, M. R., Steiner, S. M., & Mattson, M. P. (1994) · Brain Research · doi:10.1016/0006-8993(94)91586-5 · Cited by 202
Increased Neuronal β‐Amyloid Precursor Protein Expression in Human Temporal Lobe Epilepsy: Association with Interleukin‐1α Immunoreactivity
Sheng, J. G., Boop, F. A., Mrak, R. E., & Griffin, W. S. T. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051872.x · Cited by 201
Amyloid β Protein-(1–42) Forms Calcium-permeable, Zn2+-sensitive Channel
Rhee, S. K., Quist, A. P., & Lal, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13379 · Cited by 201
Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives
Behl, T., Kaur, G., Sehgal, A., Bhardwaj, S., Singh, S., Buhaș, C. L., Pusta, C. T. J., Uivaroșan, D., Munteanu, M. A., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031413 · Cited by 198
The β-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism
Petratos, S., Li, Q.-X., George, A. J., Hou, X., Kerr, M. L., Unabia, S. E., Hatzinisiriou, I., Maksel, D., Aguilar, M.-I., & Small, D. H. (2008) · Brain · doi:10.1093/brain/awm260 · Cited by 197
Inhibition of fibril formation in β-amyloid peptide by a novel series of benzofurans
Howlett, D. R., PERRY, A. E., GODFREY, F., SWATTON, J. E., JENNINGS, K. H., Spitzfaden, C. E., Wadsworth, H., Wood, S. J., & Markwell, R. E. (1999) · Biochemical Journal · doi:10.1042/bj3400283 · Cited by 197
Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers
Arispe, N. J., Díaz, J. C., & Šimáková, O. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.03.014 · Cited by 196
The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling
Roßner, S. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00044-6 · Cited by 195
Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide.
Maggio, J. E., Stimson, E. R., Ghilardi, J. R., Allen, C. J., Dahl, C. E., Whitcomb, D. C., Vigna, S. R., Vinters, H. V., Labenski, M. E., & Mantyh, P. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5462 · Cited by 195
Stimulation of α4β2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity
Kihara, T., Shimohama, S., Urushitani, M., Sawada, H., Kimura, J., Kume, T., Maeda, T., & AKAIKE, A. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00138-3 · Cited by 194
Animal models of Alzheimer's disease and evaluation of anti-dementia drugs
Yamada, K., & Nabeshima, T. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00081-4 · Cited by 192
Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1–40) and (1–42) peptides
Arispe, N. J., & Doh, M. (2002) · The FASEB Journal · doi:10.1096/fj.02-0829com · Cited by 192
Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol
Mason, R. P., Shoemaker, W. J., Shajenko, L., Chambers, T. E., & Herbette, L. G. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90116-f · Cited by 191
Neurotoxic, Redox-competent Alzheimer's β-Amyloid Is Released from Lipid Membrane by Methionine Oxidation
Barnham, K. J., Ciccotosto, G. D., Tickler, A. K., Ali, F. E. A., Smith, D. G., Williamson, N. A., Lam, Y.-H., Carrington, D., Tew, D. J., Kocak, G., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305494200 · Cited by 191
Oxidative Stress Increases Production of β-Amyloid Precursor Protein and β-Amyloid (Aβ) in Mammalian Lenses, and Aβ Has Toxic Effects on Lens Epithelial Cells
Frederikse, P. H., Garland, D. L., Zigler, J. S., & Piatigorsky, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.10169 · Cited by 190
Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium
Mattson, M. P., & Goodman, Y. (1995) · Brain Research · doi:10.1016/0006-8993(95)00148-j · Cited by 190
Enhancement of Outward Potassium Current May Participate in β-Amyloid Peptide-Induced Cortical Neuronal Death
Yu, S. P., Farhangrazi, Z. S., Ying, H. S.-C., Yeh, C.-H., & Choi, D. W. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0186 · Cited by 190
Advances in the Cellular and Molecular Biology of the Beta-Amyloid Protein in Alzheimer 's Disease
Sambamurti, K., Greig, N. H., & Lahiri, D. K. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:1:1:1 · Cited by 187
Metal ions as modulators of protein conformation and misfolding in neurodegeneration
Leal, S. S., Botelho, H. M., & Gomes, C. M. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.04.004 · Cited by 187
Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in alzheimer's disease
Heinonen, O., Soininen, H., Sorvari, H., Kosunen, O., Paljärvi, L., Koivisto, E., & Riekkinen, P. J. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00422-2 · Cited by 188
Three Histidine Residues of Amyloid-β Peptide Control the Redox Activity of Copper and Iron
Nakamura, M., Shishido, N., Nunomura, A., Smith, M. A., Perry, G. L., Hayashi, Y., Nakayama, K., & Hayashi, T. (2007) · Biochemistry · doi:10.1021/bi701079z · Cited by 184
Phosphorylation of Actin-Depolymerizing Factor/Cofilin by LIM-Kinase Mediates Amyloid -Induced Degeneration: A Potential Mechanism of Neuronal Dystrophy in Alzheimer's Disease
Heredia, L., Helguera, P. R., de Olmos, S., Kedikian, G., Vigo, F. S., LaFerla, F. M., Staufenbiel, M., de Olmos, J. S., Busciglio, J. A., Cáceres, A., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5567-05.2006 · Cited by 184
Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease
Perry, G. L., Castellani, R. J., Hirai, K., & Smith, M. A. (1998) · Journal of Alzheimer s Disease · doi:10.3233/jad-1998-1103 · Cited by 184
Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.
Gozes, I., Bardea, A., Reshef, A., Zamostiano, R., Zhukovsky, S., Rubinraut, S., Fridkin, M., & Brenneman, D. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.427 · Cited by 183
Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors.
Lee, R. K., Wurtman, R. J., Cox, A. J., & Nitsch, R. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.8083 · Cited by 181
Genetics and molecular advances in Alzheimer's disease
Mullan, M., & Crawford, F. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90007-9 · Cited by 181
Can a Bacterial Endotoxin be a Key Factor in the Kinetics of Amyloid Fibril Formation?
Asti, A., & Gioglio, L. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131394 · Cited by 180
A β 42 and A β 40: similarities and differences
Qiu, T., Liu, Q., Chen, Y., Zhao, Y., & Li, Y. (2015) · Journal of Peptide Science · doi:10.1002/psc.2789 · Cited by 180
Dense-Core Plaques in Tg2576 and PSAPP Mouse Models of Alzheimer's Disease Are Centered on Vessel Walls
Kumar‐Singh, S., Pirici, D. N., McGowan, E. M., Serneels, S., Ceuterick, C., Hardy, J., Duff, K., Dickson, D. W., & Broeckhoven, C. V. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62995-1 · Cited by 180
‘Unfolding’ pathways in neurodegenerative disease
Forman, M. S., Lee, V. M. ‐., & Trojanowski, J. Q. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00197-8 · Cited by 180
Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth.
Koo, E. H., Park, L., & Selkoe, D. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4748 · Cited by 180
Selective Phosphorylation of Adult Tau Isoforms in Mature Hippocampal Neurons Exposed to Fibrillar Aβ
Ferreira, A., Lu, Q., Orecchio, L., & Kosik, K. S. (1997) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1997.0615 · Cited by 178
Amyloid-β: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer’s disease
Kontush, A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00688-8 · Cited by 178
Isoform-Specific Effect of Apolipoprotein E on Cell Survival and β-Amyloid-Induced Toxicity in Rat Hippocampal Pyramidal Neuronal Cultures
Jordán, J., Galindo, M. F., Miller, R. J., Reardon, C. A., Getz, G. S., & LaDu, M. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00195.1998 · Cited by 139
Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy
Nalivaeva, N. N., & Turner, A. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14593 · Cited by 177
Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease
Gasparini, L., Racchi, M., Binetti, G. G., Trabucchi, M., Solerte, S. B., Alkon, D. L., Etcheberrigaray, R., Gibson, G. E., Blass, J. P., Paoletti, R., et al. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.1.17 · Cited by 177
Theoretical models of the ion channel structure of amyloid beta-protein
Durell, S. R., Guy, H. R., Arispe, N. J., Rojas, E., & Pollard, H. B. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80717-9 · Cited by 177
Galantamine-induced Amyloid-β Clearance Mediated via Stimulation of Microglial Nicotinic Acetylcholine Receptors
Takata, K., Kitamura, Y., Saeki, M., Terada, M., Kagitani, S., Kitamura, R., Fujikawa, Y., Maelicke, A., Tomimoto, H., Taniguchi, T., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.142356 · Cited by 176
Amyloid β-peptide1–42 alters tight junction protein distribution and expression in brain microvessel endothelial cells
Marco, S., & Skaper, S. D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.047 · Cited by 176
Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning
Johnson, S. A., Lampert-Etchells, M., Pasinetti, G. M., Rozovsky, I., & Finch, C. E. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90086-d · Cited by 176
The Hydrophobic Core Sequence Modulates the Neurotoxic and Secondary Structure Properties of the Prion Peptide 106‐126
Jobling, M. F., Stewart, L. R., White, A. R., McLean, C., Friedhuber, A. M., Maher, F., Beyreuther, K. T., Masters, C. L., Barrow, C. J., Collins, S. J., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731557.x · Cited by 174
Surface Behavior and Lipid Interaction of Alzheimer β-Amyloid Peptide 1–42: A Membrane-Disrupting Peptide
Ambroggio, E. E., Kim, D. H., Separovic, F., Barrow, C. J., Barnham, K. J., Bagatolli, L. A., & Fidelio, G. D. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.055582 · Cited by 174
Nerve growth factor potentiates the neurotoxicity of beta amyloid.
Yankner, B. A., Cáceres, A., & Duffy, L. K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.9020 · Cited by 174
Self-citation
Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of β-amyloid protein
Kawahara, M., Kato, M., & Kuroda, Y. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00475-0 · Cited by 173
Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF)
Erickson, J. C., Sewell, A. K., Jensen, L. T., Winge, D. R., & Palmiter, R. D. (1994) · Brain Research · doi:10.1016/0006-8993(94)91076-6 · Cited by 173
The amyloid precursor protein of Alzheimer’s disease and the Aβ peptide
Storey, & Cappai, R. (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00164.x · Cited by 172
?-amyloid Ca2+-channel hypothesis for neuronal death in Alzheimer Disease
Arispe, N. J., Pollard, H. B., & Rojas, E. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00926750 · Cited by 172

Authors: Yankner, B. A., Duffy, L. K., & Kirschner, D. A.
Affiliations: Boston Children's Hospital (US)
University of Alaska Fairbanks (US)
ORCID: Yankner, Bruce A.
Duffy, Lawrence K.
Kirschner, Daniel A.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1990-10-12
Volume: 250
Issue: 4978
Pages: 279-282
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.2218531
OpenAlex: W2059214757
Cited by: 1,975
References: 31
Citations by year: 2026: 9 · 2025: 17 · 2024: 15 · 2023: 22 · 2022: 14 · 2021: 29 · 2020: 19 · 2019: 29 · 2018: 32 · 2017: 27 · 2016: 37 · 2015: 44 · 2014: 46 · 2013: 40 · 2012: 40
FWCI: 64.80
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Aging (AG08572, R01AG008572)
National Institute of Neurological Disorders and Stroke (NS01240, K08NS001240)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: amyloid-beta, Alzheimer's disease, neurotoxicity, neurotrophic effects, tachykinin antagonists, hippocampal neurons, neuronal differentiation, neuronal cell death, dendritic retraction, axonal retraction, neurotrophic factors
MeSH terms: Amino Acid Sequence, Animals, Cells, Cultured, Embryo, Mammalian, Hippocampus, Molecular Sequence Data, Neurons, Neurotoxins, Peptide Fragments, Tachykinins, Amyloid beta-Peptides, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks